In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Lion Bioscience raises $209mm in IPO

Executive Summary

In an IPO in the US and Germany of about 5.3mm shares, bioinformatics technology developer Lion Bioscience raised about $209mm (Euro321.4mm), including the underwriter's overallotment. The company sold its shares at $39.68 each, about the midpoint of its anticipated range.
Deal Industry
  • Pharmaceuticals
  • Biotechnology
    • Drug Discovery Tools
      • Bioinformatics
      • Genomics-Proteomics
Deal Status
  • Final
Deal Type
  • Financing
    • IPO

Related Companies